The Terrible Triad of Checkpoint Inhibition: A Case Report of Myasthenia Gravis, Myocarditis, and Myositis Induced by Cemiplimab in a Patient with Metastatic Cutaneous Squamous Cell Carcinoma

BACKGROUND: We report a case of a patient with squamous cell carcinoma (SCC) who developed myasthenia gravis (MG), myositis, and myocarditis after receiving cemiplimab, an anti-PD-1 immune checkpoint inhibitor (ICI). Case Presentation. An 86-year-old man with metastatic periocular SCC presented with...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyakumar, Nikeshan, Etchegaray, Mikel, Henry, Jason, Lelenwa, Laura, Zhao, Bihong, Segura, Ana, Buja, L. Maximilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355354/
https://www.ncbi.nlm.nih.gov/pubmed/32695533
http://dx.doi.org/10.1155/2020/5126717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355354/
https://www.ncbi.nlm.nih.gov/pubmed/32695533
http://dx.doi.org/10.1155/2020/5126717

Ejemplares similares